logo

For the Inventor, By the Inventor

Gurnee, IL, United States of America

Lori A Schretzman

USPTO Granted Patents = 13

 

Average Co-Inventor Count = 6.2

ph-index = 4

Forward Citations = 39(Granted Patents)


Company Filing History:

goldMedal10 out of 1,323 
 
G.d. Searle & Company
 patents
silverMedal3 out of 200 
 
Pharmacia Corporation
 patents

Years Active: 1996-2006

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 7119098 - Heteroarylakanoic acids as intergrin receptor antagonists (2006-10-10),
2. 6933304 - Heteroarylalkanoic acids as integrin receptor antagonists (2005-08-23),
3. 6683077 - 2-Amino-benzoxazinones for the treatment of viral infections (2004-01-27),
4. 6531494 - Gem-substituted &agr;v&bgr;3 antagonists (2003-03-11),
5. 6380189 - 2-amino benzoxazinones for the treatment of viral infections (2002-04-30),
6. 6025358 - Double prodrugs of potent GP IIb/IIIa antagonists (2000-02-15),
7. 5985872 - 2-amino-benzoxazinones for the treatment of viral infections (1999-11-16),
8. 5721366 - Platelet aggregation inhibitors (1998-02-24),
9. 5659063 - Intermediates for amidino phenyl pyrrolidine .beta.-alanine urea analogs (1997-08-19),
10. 5610296 - Process for the preparation of amidino phenyl pyrrolidine beta-alanine (1997-03-11),
11. 5576447 - Process for the preparation of amidino phenyl pyrrolidine .beta.-alanine (1996-11-19),
12. 5484946 - Process for the preparation of amidino phenyl pyrrolidine .beta.-alanine (1996-01-16),
13. 5481021 - Phenyl amidines derivatives useful as platelet aggregation inhibitors (1996-01-02),

Title: Lori A Schretzman: Innovator in Pharmaceutical Chemistry

Introduction

Lori A Schretzman is a prominent inventor based in Gurnee, IL (US), known for her significant contributions to pharmaceutical chemistry. With a total of 13 patents to her name, she has made remarkable advancements in the field of integrin receptor antagonists.

Latest Patents

Among her latest patents are "Heteroarylakanoic acids as integrin receptor antagonists." This invention relates to a class of compounds represented by a specific formula or a pharmaceutically acceptable salt thereof. The pharmaceutical compositions comprising these compounds are designed to selectively antagonize the αβ and/or the αβ integrin without significantly affecting the IIb/IIIa integrin. Another notable patent is also titled "Heteroarylalkanoic acids as integrin receptor antagonists," which shares similar characteristics and applications.

Career Highlights

Lori has worked with notable companies such as G.D. Searle & Company and Pharmacia Corporation. Her work in these organizations has contributed to her expertise and innovation in the pharmaceutical industry.

Collaborations

Some of her coworkers include Norman A Abood and Daniel L Flynn, who have collaborated with her on various projects throughout her career.

Conclusion

Lori A Schretzman exemplifies the spirit of innovation in pharmaceutical chemistry through her extensive patent portfolio and collaborative efforts. Her work continues to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…